Lastly, a role of autophagy to trigger mutant, but not WT, P53 deprivation has been shown in different cancer cells (58–60), identifying the modulation of autophagy as an emerging strategy for cancer therapy (61, 62). This evidence concerns the gene TP53 and cancer.